Rapid Dose Therapeutics Corp.
DOSE
Rank in Stocks
#28975
Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life... Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company's flagship product is QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter medicines—directly into the bloodstream. They offer specific QuickStrip variants like QuickStrip energy for caffeine delivery, QuickStrip B12 for vitamin B12 supplementation, and QuickStrip sleep for melatonin. Beyond its proprietary products, the firm also delivers comprehensive services encompassing product innovation, manufacturing, and consultation to industries including nutraceuticals, cannabis healthcare, and pharmaceutical production. Rapid Dose Therapeutics maintains a significant research collaboration with McMaster University, focusing on crafting enhanced biopolymer compositions for oral dissolvable thin films and investigating an orally administered vaccine candidate for COVID-19.
Share Price
$0.06727378
Last synced: 2026-11-09
Market Cap
$9.27M
Change (1 day)
-9.52%
Change (1 year)
-30.14%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Rapid Dose Therapeutics Corp. (DOSE)
Category
Healthcare
EPS for Rapid Dose Therapeutics Corp. (DOSE)
EPS as of August 2026 TTM: $-0.02
According to Rapid Dose Therapeutics Corp.'s latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.03, equal to its 2024 EPS of $-0.03.
EPS history for Rapid Dose Therapeutics Corp. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | -44.00% |
| 2025 | $-0.03 | -0.66% |
| 2024 | $-0.03 | 11.85% |
| 2023 | $-0.03 | -57.28% |
| 2022 | $-0.06 | 300.00% |
| 2021 | $-0.02 | -78.79% |
| 2020 | $-0.07 | -45.50% |
| 2019 | $-0.14 | 276.58% |
| 2017 | $-0.04 | -18.61% |
| 2016 | $-0.04 | -45.87% |
| 2015 | $-0.08 | 29.97% |
| 2014 | $-0.06 | -9.30% |
| 2013 | $-0.07 | -89.58% |
| 2012 | $-0.67 | 180.32% |
| 2011 | $-0.24 | 44.94% |
| 2010 | $-0.17 | 678.77% |
| 2009 | $-0.02 | 98.13% |
| 2008 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -93,314.29% |
US
|
|
| $-7.07 | 41,983.33% |
US
|
|
| $-5.29 | 31,388.10% |
AU
|
|
| $12.88 | -76,767.26% |
BE
|
|
| $21.56 | -128,433.33% |
NL
|
Questions about Rapid Dose Therapeutics Corp.'s earnings per share (EPS)
What is Rapid Dose Therapeutics Corp.'s earnings per share (EPS)?
Rapid Dose Therapeutics Corp.'s earnings per share (EPS) over the last twelve months is $-0.02, as of Aug 2026.
What was Rapid Dose Therapeutics Corp.'s earnings per share (EPS) in 2025?
In 2025, Rapid Dose Therapeutics Corp.'s earnings per share (EPS) was $-0.03, compared with $-0.03 in 2024.
How has Rapid Dose Therapeutics Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Rapid Dose Therapeutics Corp.'s earnings per share (EPS) was highest in 2021 ($-0.02) and lowest in 2020 ($-0.07).
How does Rapid Dose Therapeutics Corp.'s earnings per share (EPS) compare with similar companies?
Rapid Dose Therapeutics Corp.'s earnings per share (EPS) ($-0.02) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.